Nanotech Indonesia Global Tbk PT - Asset Resilience Ratio
Nanotech Indonesia Global Tbk PT (NANO) has an Asset Resilience Ratio of 1.51% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read NANO current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2022)
This chart shows how Nanotech Indonesia Global Tbk PT's Asset Resilience Ratio has changed over time. See Nanotech Indonesia Global Tbk PT shareholders equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Nanotech Indonesia Global Tbk PT's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see NANO stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp3.20 Billion | 1.51% |
| Short-term Investments | Rp0.00 | 0% |
| Total Liquid Assets | Rp3.20 Billion | 1.51% |
Asset Resilience Insights
- Limited Liquidity: Nanotech Indonesia Global Tbk PT maintains only 1.51% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Nanotech Indonesia Global Tbk PT Industry Peers by Asset Resilience Ratio
Compare Nanotech Indonesia Global Tbk PT's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 36.63% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 9.52% |
|
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562 |
Medical Devices | 14.72% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.47% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 0.50% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.39% |
Annual Asset Resilience Ratio for Nanotech Indonesia Global Tbk PT (2022–2022)
The table below shows the annual Asset Resilience Ratio data for Nanotech Indonesia Global Tbk PT.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 0.05% | Rp100.00 Million ≈ $5.86K |
Rp182.74 Billion ≈ $10.71 Million |
-- |
About Nanotech Indonesia Global Tbk PT
PT Nanotech Indonesia Global Tbk, a technology company, engages in the field of research and development (R&D)-based science and technology services, materials engineering, and nanotechnology. It operates in two segments, Service and Trading. The company operates in materials, health, cosmetics, pharmacy, agribusiness and aquaculture, inspection, property and construction, and education businesse… Read more